CLINICAL_TRIALS
research
· 2025-12-02
Clinical Trial Update: Prucalopride for Cognitive Functioning in Schizophrenia [NA]
Summary
A ClinicalTrials.gov entry describes a study investigating prucalopride for improving cognitive functioning in individuals with schizophrenia. The trial status …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Pittsburgh | Conditions: Schizophrenia | NA | Status: NOT_YET_RECRUITING